Burning Rock Biotech Limited
A precision oncology company based in Guangzhou, China, that reads the DNA of tumors to help doctors pick the right cancer treatments and to catch cancers early. Its blood tests and kits — sold under brands like OncoScreen, OverC, and CanCatch — are used by cancer patients, hospitals, and drugmakers. Founded in 2014, the company takes its name from the image of a "burning rock," meant to capture resilience and the intense drive to fight cancer. Its mission is summed up as "Guard Life via Science."
American Depositary Shares (ADS)
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Kynam Capital Management, LP | 13G/APassive | 13.97% | 0 | May 15, 2026 |
| Kynam Capital Management GP, LLC | 13G/APassive | 13.97% | 0 | May 15, 2026 |
| Yue Tang | 13G/APassive | 13.97% | 0 | May 15, 2026 |
| CRCM LP | 13G/APassive | 3.2% | 282.1K | May 13, 2026 |
| CRCM LLC | 13G/APassive | 3.2% | 282.1K | May 13, 2026 |
| Ding Chun R | 13G/APassive | 3.2% | 282.1K | May 13, 2026 |
| CRCM INSTITUTIONAL MASTER FUND (BVI), LTD. | 13G/APassive | 3.1% | 275.0K | May 13, 2026 |